Articles On Race Oncology (ASX:RAC)

Title Source Codes Date
ScoPo’s Powerplays: Health sector trades sideways but M&A plays coloured the week

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week Healthcare f...

Stockhead RAC 2 days ago
Race Oncology completes oversubscribed placement

Race Oncology (ASX:RAC) says it has received binding commitments to raise $5.4 million before costs in an oversubscribed equity placement to new and existing institutional and sophisticated investors.

BiotechDispatch RAC 4 days ago
Race Oncology Share Price Are up after a Successful Share (ASX:RAC)

The Cancer fighting biotech company Race Oncology Ltd [ASX:RAC] share price is up 4.23% today. Rising higher after coming out of trading halt, and announcing the successful completion of a share placement... The post Race Oncology Share Pr...

MoneyMorning RAC 4 days ago
Closing Bell: ASX200 hits a 14-month high of 7,100, Nearmap enters halt after 14% gain

Summary The ASX 200 crosses 7100 mark, its 14-month highest level since the coronavirus pandemic-led sell-off triggered in February last year. The market witnessed broad-based rally, with nine of 11 sectors trading in green. Nearmap s...

Kalkine Media RAC 4 days ago
Here’s why ASX healthcare shares Neurotech and AFT Pharma are trending today

Summary Neurotech International has commenced Phase I/II open-label clinical trial in children having Autism Spectrum Disorder. Multinational pharmaceutical company AFT Pharmaceuticals disclosed the extension of licensing of Maxigesic®...

Kalkine Media RAC 5 days ago
Why Ecofibre, MoneyMe, Nearmap, & Race Oncology shares are storming higher

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, the benchmark index is up 0.75% to 7,120.3 points. Four ASX shares that are climbing more than most today are listed bel...

Motley Fool RAC 5 days ago
Here’s why the Race Oncology (ASX:RAC) share price is leaping higher

The Race Oncology Ltd (ASX: RAC) share price is gaining today, up 5% in late morning trade. The ASX healthcare share entered a trading halt on Monday prior to disclosing the details of a capital raising, which it released this morning. Rac...

Motley Fool RAC 5 days ago
Last Orders: Tech stocks lost nearly 2 per cent; but the rest of the ASX in the green

On a day the ASX finished nearly 0.5 per cent up, tech stood alone in the red losing more than 2 per cent. The ASX 200 closed 0.56 per cent up at 7,068 points and the ASX Emerging Companies Index rose 0.41 per cent closing at 2,111 points....

Stockhead RAC 5 days ago
Race Oncology (ASX RAC) is a Potential Acquisition Target in a $530B M&A Market

Today we will take a look at why we like Race Oncology (ASX RAC). Race Oncology (ASX RAC) is a precision oncology company with a phase II/III cancer drug called Bisantrene. The aim of the company is to build value in Bisantrene through proo...

MFAM RAC 6 days ago
Last Orders: The ASX starts the week slightly higher

After gaining 0.5 per cent in the first hour of trade the ASX only finished slightly upwards. The ASX 200 closed at 7,029 points, which was 0.04 per cent higher than Friday. Small caps had a worse day – the ASX Emerging Companies Index clos...

Stockhead RAC 6 days ago
Why the Race Oncology (ASX:RAC) share price is frozen

Race Oncology Ltd (ASX: RAC) shares are in a trading halt today as the company seeks to raise an undisclosed amount of capital. At Friday’s close, the Race Oncology share price was trading at $3.07 after significant falls over the past wee...

Motley Fool RAC 1 week ago
Did the March quarter updates for 5GN, JBH, CPT bring cheer to the market?

Summary 5G Networks reported robust growth across all three core products in Q3 FY21 and witnessed a growing demand for the 5GN Voice Bridge One Microsoft Teams product. JB Hi-Fi witnessed double-digit sales growth in two of its three...

Kalkine Media RAC 1 week ago
ASX healthcare shares OVN and ECS trading in red despite positive March quarter 

Summary Oventus Medical witnessed growth in booked revenue and acceleration in telehealth bookings in Q3 FY21. ECS Botanics Holdings’ March 2021 quarter was action-packed with a major acquisition and multiple supply agreements. Despit...

Kalkine Media RAC 1 week ago
Why are ASX healthcare stocks RAC and AHI trending today?

Summary Race Oncology Limited has entered into a collaboration for the preclinical study of its cancer drug Bisantrene in heart safety. Advanced Human Imaging has executed a Binding Heads of Agreement for the proposed acquisition of Ph...

Kalkine Media RAC 1 week ago
Why the Race Oncology (ASX:RAC) share price is racing higher

The Race Oncology Ltd (ASX: RAC) share price is climbing today after an update from the Aussie healthcare company. Why is the Race Oncology share price climbing? Race Oncology announced that it has entered into a collaborative preclinical...

Motley Fool RAC 1 week ago
How did ASX healthcare shares MXC and RAC perform in March 2021 quarter?

Summary Medicinal cannabis player MGC Pharmaceuticals has a historic quarter with the ground-breaking achievement of listing on the LSE. Oncology company Race Oncology has an action-packed quarter with significant progress on the Three...

Kalkine Media RAC 1 week ago
Why were Australian healthcare shares EX1 and RAC trending today?

Summary Exopharm obtained firm commitments from institutional and sophisticated investors to raise a total of AU$12 million. Race Oncology announced that its new Chief Medical Officer, Dr David Fuller, is set to join on 1 July 2021....

Kalkine Media RAC 2 weeks ago
Race Oncology appoints chief medical officer

Race Oncology (ASX:RAC) has announced the appointment of Dr David Fuller as its chief medical officer.

BiotechDispatch RAC 2 weeks ago
Last Orders: ASX edges further towards pre-pandemic record high

It was another day in the green for the ASX as it edged closer to surpassing the record high it reached immediately prior to COVID-19. The ASX 200 rose 0.51 per cent, closing at 7,058 points while the ASX Emerging Companies Index rose 0.75...

Stockhead RAC 3 weeks ago
Why Ampol, Netwealth, Orocobre, & Race Oncology shares are storming higher

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is out of form and edging slightly lower. At the time of writing, the benchmark index is down a few points to 7,020 points. Four ASX shares that are not letting that hold them back a...

Motley Fool RAC 3 weeks ago
Why the Race Oncology (ASX:RAC) share price is rocketing 10% higher

The Race Oncology Ltd (ASX: RAC) share price has been a very strong performer on Thursday. In morning trade, the precision oncology company’s shares are up 10% to $3.38. Why is the Race Oncology share price storming higher? Investors have...

Motley Fool RAC 3 weeks ago
IPO Watch: Mosquito disease fighter Island Pharmaceuticals doubles on debut

Another day, another IPO – today the new listee was biotech Island Pharmaceuticals (ASX:ILA). Island Pharmaceuticals is one of the few biotechs fighting mosquito diseases, particularly dengue fever. Its flagship drug ISLA-101 was originally...

Stockhead RAC 3 weeks ago
Uranium explorer 92 Energy eyes ASX listing for mid-April

Uranium explorer 92 Energy (ASX:92E) is among several companies lined up to list on the ASX this or next week after bioenergy company Delorean joined the bourse yesterday. There are four IPOs timed for this week, including Delorean (ASX: DE...

Stockhead RAC 3 weeks ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday t...

Stockhead RAC 1 month ago
Why Computershare, Macquarie, Race Oncology, & Webjet are tumbling lower

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to end the shortened week with a small gain. At the time of writing, the benchmark index is up 0.2% to 6,805.7 points. Four ASX shares that have failed to follow the mark...

Motley Fool RAC 1 month ago
Looking to Jazz Up Your Easter Basket? Here are 7 Hot Stocks to Explore

Source:WHYFRAME, Shutterstock Summary Huge market volatility has been observed in 2021 so far amid the tug of war between surging COVID-19 cases and progress in economic recovery. Volatility is expected to continue over the coming day...

Kalkine Media RAC 1 month ago
Race (ASX:RAC) share price falters despite positive update

The Race Oncology Ltd (ASX: RAC) share price is struggling in early-morning trade despite the company announcing the initiation of an extramedullary AML preclinical study. At the time of writing, the specialty pharmaceutical company’s shar...

Motley Fool RAC 1 month ago
ScoPo’s powerplays: His Mach7 pick paid off – will Impedimed rise as well?

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week “Another s...

Stockhead RAC 1 month ago
Last Orders: ASX finishes up despite investors jumping off Airtasker float

The ASX finished the day slightly in the green, dragged down by tech stocks which lost nearly 1.5 per cent and new float Airtasker (ASX:ART) fell by over 20 per cent. Airtasker debuted at 65 cents and rose over Tuesday and Wednesday to over...

Stockhead RAC 1 month ago
Why are these two Australian healthcare shares trending – RAC, 4DX?

Source: Tyler Olson, Shutterstock Summary ASX-listed oncology player Race Oncology to explore the use of Bisantrene for the treatment of ccRCC. 4DMedical to secure contracts with DoD and VA facilities for its XV LVAS with a pre-agreed...

Kalkine Media RAC 1 month ago
Up 1,460% in a year, why the Race Oncology (ASX:RAC) share price is sliding today

Race Oncology Ltd (ASX: RAC) shares are slipping in late morning trade despite the company providing a positive update. At the time of writing, the Race share price has slumped 1.27% lower to $3.90. Below we take a look at the ASX healthca...

Motley Fool RAC 1 month ago
One year on: The top ASX performers since COVID-19 doomsday on March 23, 2020

On this day last year, global stocks capped off a historic one-month collapse with another epic fall. While no one knew at the time, that marked the COVID-19 nadir. Over the course of the following week, governments around the world said ju...

Stockhead RAC 1 month ago
Race Oncology and Bard1 had an eventful week. Here’s why

Source: Blue Planet Studio, Shutterstock Summary Oncology player Race Oncology has collaborated with the University of Newcastle for its preclinical research program to study Bisantrene in melanoma. Leading Australian diagnostics play...

Kalkine Media RAC 1 month ago
Race Oncology (ASX:RAC) share price slides on a new melanoma preclinical study

The Race Oncology Ltd (ASX: RAC) share price is sliding today, despite the announcement of a new preclinical study by the specialty pharmaceutical company. At the time of writing, shares are down 0.5% to $3.98. Race Oncology share price un...

Motley Fool RAC 1 month ago
Check Up: Oneview leads healthcare sector after ‘investor awareness’ pact

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Stockhead RAC 1 month ago
Why are Race Oncology (ASX:RAC) shares riding high today?

Source: fizkes ,Shutterstock Summary Race Oncology announced the positive final results of its preclinical research program for Bisantrene. The results demonstrated that Bisantrene was an effective cancer treatment for genetically dis...

Kalkine Media RAC 2 months ago
Race Oncology (ASX: RAC) share price higher on preclinical breast cancer results

The Race Oncology Ltd (ASX: RAC) share price is 9.4% higher at the time of writing following preclinical breast cancer results.  Race Oncology share price on the move after compelling results  Race Oncology is developing a cancer-fighting...

Motley Fool RAC 2 months ago
Subreddit ASX Bets is gambling these 4 ASX shares will follow in GameStop’s footsteps

At the end of January, the GameStop Corp. (NYSE: GME) share price hit an all-time high of US$483. Only 2 months previously, shares in the company were trading at US$14.75. Many attributed the video game retailer’s dramatic rise to subreddi...

Motley Fool RAC 2 months ago
Three momentum stocks for March 2021

Source: ImageFlow,Shutterstock Summary Momentum investing is a relatively newer approach that primarily capitalises on the share price momentum. TPC consolidated has started March 2021 with a bang, delivering 23.81 per cent on Monday....

Kalkine Media RAC 2 months ago
Trending Penny stocks for today 

Source: schankz, Shutterstock Summary The Australian share market’s outlook appears exciting as the economy recovers from the coronavirus-induced disruptions.  The investors could use the opportunity to beef up their portfolios with s...

Kalkine Media RAC 2 months ago
Up 61% in 2021, why the Race Oncology (ASX:RAC) share price is marching higher again

Hot on the heels of yesterday’s gains, Race Oncology Ltd (ASX: RAC) shares were marching higher again today. By the market’s close, the Race Oncology share price had jumped 2.27% to $3.15. That puts the total gains for the company’s shares...

Motley Fool RAC 2 months ago
Race Oncology updates on pre-clinical research of Bisantrene

Race Oncology (ASX:RAC) has released further interim results from its continuing collaborative preclinical research program with The University of Newcastle.

BiotechDispatch RAC 2 months ago
What sent the Race Oncology (ASX:RAC) share price rocketing 20% today?

The Race Oncology Ltd (ASX: RAC) share price rocketed 20.98% today, closing the day at $2.48 per share. Race Oncology Ltd (RAC) is an Australian pharmaceutical company with developments in the cancer field. The company produces a chemother...

Motley Fool RAC 3 months ago
Invex Therapeutics pushes on with phase three trial design to repurpose drug for brain disorder

Invex Therapeutics (ASX: IXC) is aiming to hit some significant milestones in 2021 in its bid to use a diabetic drug for a neurological condition in desperate need for treatment. The biopharmaceutical company is focused on repurposing the d...

SmallCaps RAC 3 months ago
Lens Through 10 Popular ASX-Listed Healthcare Players of 2020

Summary The intensity of adoption of tech-enabled health solutions has shot up amidst government restrictions and infection risks amidst COVID-19. Burgeoning demand for healthcare products kept healthcare stocks under the spotlight in...

Kalkine Media RAC 4 months ago
ASX small caps could get a boost with the Aussie dollar hitting 28-month highs

The rebound in the S&P/ASX 200 Index (Index:^AXJO) might be grabbing headlines with its dramatic rebound, but it’s the ASX small caps that’re outperforming. What’s more, the market minnows might keep their lead as we head into 2021 wit...

Motley Fool RAC 5 months ago
Hidden Gems Webinar Recap – OSP, PYG, AGC, RAC

ShareCafeHidden Gems Webinar Recap – OSP, PYG, AGC, RAC Catch up on the full webinar with presentations from Osprey Medical Inc (ASX: OSP), Paygroup Limited (ASX: PYG), Australian Gold and Copper Limited (ASX:AGC) and Race Oncology Limited...

ShareCafe RAC 5 months ago
Race Oncology Limited (ASX:RAC) – Hidden Gems Webinar Presentation

ShareCafeRace Oncology Limited (ASX:RAC) – Hidden Gems Webinar Presentation Presenter – Dr Daniel Tillett – Race Oncology is an ASX listed precision oncology company with a Phase II/III cancer drug called Bisantrene. Bisantrene is a potent...

ShareCafe RAC 5 months ago
Race Oncology Share Price Reaches New High (ASX:RAC)

At time of writing the RAC share price is trading at $2.12 up 7.07%. Race Oncology Ltd (ASX:RAC) announced the initiation of a breast cancer clinical trial program... The post Race Oncology Share Price Reaches New High (ASX:RAC) appeared fi...

MoneyMorning RAC 5 months ago
Race Oncology updates on results of Bisantrene study

Race Oncology (ASX: RAC) has shared the results of the preclinical research program it is undertaking as part of a collaboration with The University of Newcastle.

BiotechDispatch RAC 5 months ago